147 related articles for article (PubMed ID: 17671675)
1. Immunohistochemical detection of the lymphatic marker podoplanin in diverse types of human cancer cells using a novel antibody.
Kono T; Shimoda M; Takahashi M; Matsumoto K; Yoshimoto T; Mizutani M; Tabata C; Okoshi K; Wada H; Kubo H
Int J Oncol; 2007 Sep; 31(3):501-8. PubMed ID: 17671675
[TBL] [Abstract][Full Text] [Related]
2. Characterization of monoclonal antibody LpMab-3 recognizing sialylated glycopeptide of podoplanin.
Oki H; Ogasawara S; Kaneko MK; Takagi M; Yamauchi M; Kato Y
Monoclon Antib Immunodiagn Immunother; 2015 Feb; 34(1):44-50. PubMed ID: 25723283
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.
Mishima K; Kato Y; Kaneko MK; Nishikawa R; Hirose T; Matsutani M
Acta Neuropathol; 2006 May; 111(5):483-8. PubMed ID: 16596424
[TBL] [Abstract][Full Text] [Related]
4. High-level expression of podoplanin in benign and malignant soft tissue tumors: immunohistochemical and quantitative real-time RT-PCR analysis.
Xu Y; Ogose A; Kawashima H; Hotta T; Ariizumi T; Li G; Umezu H; Endo N
Oncol Rep; 2011 Mar; 25(3):599-607. PubMed ID: 21234520
[TBL] [Abstract][Full Text] [Related]
5. [Podoplanin--a specific marker for lymphatic endothelium expressed in angiosarcoma].
Breiteneder-Geleff S; Soleiman A; Horvat R; Amann G; Kowalski H; Kerjaschki D
Verh Dtsch Ges Pathol; 1999; 83():270-5. PubMed ID: 10714221
[TBL] [Abstract][Full Text] [Related]
6. Characterization and distribution in normal and tumoral human tissues of breast cancer-associated antigen defined by monoclonal antibody 7B10.
Pancino GF; Le Doussal V; Mortada MH; Berthon P; Osinaga E; Calvo F; Roseto A
Cancer Res; 1989 Dec; 49(24 Pt 1):7078-85. PubMed ID: 2555058
[TBL] [Abstract][Full Text] [Related]
7. The role of podoplanin in tumor progression and metastasis.
Raica M; Cimpean AM; Ribatti D
Anticancer Res; 2008; 28(5B):2997-3006. PubMed ID: 19031946
[TBL] [Abstract][Full Text] [Related]
8. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors.
Schacht V; Dadras SS; Johnson LA; Jackson DG; Hong YK; Detmar M
Am J Pathol; 2005 Mar; 166(3):913-21. PubMed ID: 15743802
[TBL] [Abstract][Full Text] [Related]
10. [Identification of the novel platelet activation receptor CLEC-2 and Its pathological and physiological roles].
Suzuki Inoue K; Inoue O; Ozaki Y
Rinsho Byori; 2010 Dec; 58(12):1193-202. PubMed ID: 21348239
[TBL] [Abstract][Full Text] [Related]
11. D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma.
Ordóñez NG
Hum Pathol; 2005 Apr; 36(4):372-80. PubMed ID: 15891998
[TBL] [Abstract][Full Text] [Related]
12. Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases.
Adachi Y; Nakamura H; Kitamura Y; Taniguchi Y; Araki K; Shomori K; Horie Y; Kurozawa Y; Ito H; Hayashi K
Pathol Int; 2007 Apr; 57(4):171-7. PubMed ID: 17316411
[TBL] [Abstract][Full Text] [Related]
13. Podoplanin: a novel diagnostic immunohistochemical marker.
Ordóñez NG
Adv Anat Pathol; 2006 Mar; 13(2):83-8. PubMed ID: 16670463
[TBL] [Abstract][Full Text] [Related]
14. Podoplanin expression in primary central nervous system germ cell tumors: a useful histological marker for the diagnosis of germinoma.
Mishima K; Kato Y; Kaneko MK; Nakazawa Y; Kunita A; Fujita N; Tsuruo T; Nishikawa R; Hirose T; Matsutani M
Acta Neuropathol; 2006 Jun; 111(6):563-8. PubMed ID: 16718353
[TBL] [Abstract][Full Text] [Related]
15. Functional sialylated O-glycan to platelet aggregation on Aggrus (T1alpha/Podoplanin) molecules expressed in Chinese hamster ovary cells.
Kaneko M; Kato Y; Kunita A; Fujita N; Tsuruo T; Osawa M
J Biol Chem; 2004 Sep; 279(37):38838-43. PubMed ID: 15231832
[TBL] [Abstract][Full Text] [Related]
16. Lymphatic vessel density and lymph node metastasis in prostate cancer.
Zeng Y; Opeskin K; Horvath LG; Sutherland RL; Williams ED
Prostate; 2005 Nov; 65(3):222-30. PubMed ID: 15948136
[TBL] [Abstract][Full Text] [Related]
17. A novel targeting therapy of malignant mesothelioma using anti-podoplanin antibody.
Abe S; Morita Y; Kaneko MK; Hanibuchi M; Tsujimoto Y; Goto H; Kakiuchi S; Aono Y; Huang J; Sato S; Kishuku M; Taniguchi Y; Azuma M; Kawazoe K; Sekido Y; Yano S; Akiyama S; Sone S; Minakuchi K; Kato Y; Nishioka Y
J Immunol; 2013 Jun; 190(12):6239-49. PubMed ID: 23690472
[TBL] [Abstract][Full Text] [Related]
18. Tumorigenic role of podoplanin in esophageal squamous-cell carcinoma.
Rahadiani N; Ikeda J; Makino T; Tian T; Qiu Y; Mamat S; Wang Y; Doki Y; Aozasa K; Morii E
Ann Surg Oncol; 2010 May; 17(5):1311-23. PubMed ID: 20066519
[TBL] [Abstract][Full Text] [Related]
19. Lymphatics and D2-40/podoplanin expression in gastrointestinal stromal tumours of the stomach with and without lymph node metastasis: an immunohistochemical study with special reference to the Carney triad.
Agaimy A; Carney JA
J Clin Pathol; 2010 Mar; 63(3):229-34. PubMed ID: 20203222
[TBL] [Abstract][Full Text] [Related]
20. Chimeric Anti-Human Podoplanin Antibody NZ-12 of Lambda Light Chain Exerts Higher Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity Compared with NZ-8 of Kappa Light Chain.
Kaneko MK; Abe S; Ogasawara S; Fujii Y; Yamada S; Murata T; Uchida H; Tahara H; Nishioka Y; Kato Y
Monoclon Antib Immunodiagn Immunother; 2017 Feb; 36(1):25-29. PubMed ID: 28157429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
